{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:51:17Z","timestamp":1790193077818,"version":"4.1.0"},"reference-count":207,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.phrs.2016.12.017","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T01:47:07Z","timestamp":1481766427000},"page":"57-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["The opposing roles of NO and oxidative stress in cardiovascular disease"],"prefix":"10.1016","volume":"116","author":[{"given":"Rebecca H.","family":"Ritchie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant R.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Sobey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Michael","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K.","family":"Kemp-Harper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"176 Pt 1","key":"10.1016\/j.phrs.2016.12.017_bib0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/3-540-32967-6_7","article-title":"Nitric oxide and the vascular endothelium","author":"Moncada","year":"2006","journal-title":"Handb. Exp. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0010","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1172\/JCI119750","article-title":"Nitric oxide synthases: which, where, how, and why?","volume":"100","author":"Michel","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0015","doi-asserted-by":"crossref","first-page":"H365","DOI":"10.1152\/ajpheart.00495.2012","article-title":"HNO\/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NO","volume":"305","author":"Irvine","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0020","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1161\/01.HYP.0000032854.74042.CF","article-title":"Acute antihypertrophic actions of bradykinin in the rat heart: importance of cyclic GMP","volume":"40","author":"Rosenkranz","year":"2002","journal-title":"Hypertension"},{"issue":"4 Pt. 2","key":"10.1016\/j.phrs.2016.12.017_bib0025","first-page":"H1370","article-title":"Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide","volume":"275","author":"Ritchie","year":"1998","journal-title":"Am. J. Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0030","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pharmthera.2009.08.001","article-title":"Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO* and beyond","volume":"124","author":"Ritchie","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.12.017_bib0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.phrs.2015.12.006","article-title":"The HNO donor Angeli\u2019s salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia-reperfusion injury in the rat heart ex vivo","volume":"104","author":"Chin","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2016.12.017_bib0040","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.2741\/1621","article-title":"Tracking functions of cGMP-dependent protein kinases (cGK)","volume":"10","author":"Lohmann","year":"2005","journal-title":"Front. Biosci."},{"issue":"191","key":"10.1016\/j.phrs.2016.12.017_bib0045","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/978-3-540-68964-5_19","article-title":"cGMP in the vasculature","author":"Kemp-Harper","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCRESAHA.109.207381","article-title":"S-Nitrosylation in cardiovascular signaling","volume":"106","author":"Lima","year":"2010","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0055","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/01.CIR.104.2.191","article-title":"Prognostic significance of endothelial dysfunction in hypertensive patients","volume":"104","author":"Perticone","year":"2001","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0060","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1161\/01.CIR.91.6.1732","article-title":"Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway","volume":"91","author":"Panza","year":"1995","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0065","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.CIR.101.9.948","article-title":"Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction","volume":"101","author":"Suwaidi","year":"2000","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.phrs.2016.12.017_bib0070","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s001250051551","article-title":"Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus","volume":"43","author":"Heitzer","year":"2000","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cardfail.2010.09.003","article-title":"The l-arginine-asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training","volume":"17","author":"Seljeflot","year":"2011","journal-title":"J. Card. Fail."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.niox.2011.04.009","article-title":"The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterload","volume":"25","author":"Sverdlov","year":"2011","journal-title":"Nitric Oxide"},{"issue":"10","key":"10.1016\/j.phrs.2016.12.017_bib0085","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jacc.2012.01.066","article-title":"Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients","volume":"60","author":"Willoughby","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.phrs.2016.12.017_bib0090","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/01.CIR.101.16.1899","article-title":"Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease","volume":"101","author":"Schachinger","year":"2000","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.phrs.2016.12.017_bib0095","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1089\/ars.2008.2027","article-title":"Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities","volume":"10","author":"Thomas","year":"2008","journal-title":"Antioxid. Redox Signal."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tips.2013.03.007","article-title":"Oxidative stress in vascular disease and its pharmacological prevention","volume":"34","author":"Li","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"14","key":"10.1016\/j.phrs.2016.12.017_bib0105","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1089\/ars.2015.6430","article-title":"Pharmacology and clinical drug candidates in redox medicine","volume":"23","author":"Dao","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0110","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrd3403","article-title":"Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets","volume":"10","author":"Drummond","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0115","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tem.2014.06.012","article-title":"Endothelial NADPH oxidases: which NOX to target in vascular disease?","volume":"25","author":"Drummond","year":"2014","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2016.12.017_bib0120","series-title":"Endothelial Dysfunction and Inflammation","first-page":"37","article-title":"Oxidative stress and endothelial dysfunction","author":"de Dios","year":"2010"},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0125","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pharmthera.2008.08.005","article-title":"NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition","volume":"120","author":"Selemidis","year":"2008","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1179\/174329210X12650506623401","article-title":"Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models","volume":"15","author":"Rivera","year":"2010","journal-title":"Redox Rep."},{"issue":"6061","key":"10.1016\/j.phrs.2016.12.017_bib0135","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/320454a0","article-title":"Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor","volume":"320","author":"Gryglewski","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2016.12.017_bib0140","first-page":"339","article-title":"The interactions of nitric oxide with oxygen radicals and scavengers in cerebral ischemic injury","volume":"71","author":"Beckman","year":"1996","journal-title":"Adv. Neurol."},{"issue":"25","key":"10.1016\/j.phrs.2016.12.017_bib0145","doi-asserted-by":"crossref","first-page":"22546","DOI":"10.1074\/jbc.M302227200","article-title":"Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase","volume":"278","author":"Kuzkaya","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0150","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cardiores.2007.03.030","article-title":"Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells","volume":"75","author":"Selemidis","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0155","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0160","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCRESAHA.109.198234","article-title":"Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation","volume":"105","author":"Meurer","year":"2009","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0170","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/01.RES.85.6.534","article-title":"Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats","volume":"85","author":"Ruetten","year":"1999","journal-title":"Circ. Res."},{"issue":"47","key":"10.1016\/j.phrs.2016.12.017_bib0175","doi-asserted-by":"crossref","first-page":"16671","DOI":"10.1073\/pnas.0405509101","article-title":"Reduced cGMP signaling associated with neointimal proliferation and vascular dysfunction in late-stage atherosclerosis","volume":"101","author":"Melichar","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.phrs.2016.12.017_bib0180","doi-asserted-by":"crossref","first-page":"e44481","DOI":"10.1371\/journal.pone.0044481","article-title":"The soluble guanylyl cyclase activator bay 58-2667 selectively limits cardiomyocyte hypertrophy","volume":"7","author":"Irvine","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0185","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehs196","article-title":"Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure","volume":"34","author":"Erdmann","year":"2013","journal-title":"Eur. Heart J."},{"issue":"20","key":"10.1016\/j.phrs.2016.12.017_bib0190","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.110.981738","article-title":"Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease","volume":"123","author":"Stasch","year":"2011","journal-title":"Circulation"},{"issue":"5 Pt. 1","key":"10.1016\/j.phrs.2016.12.017_bib0195","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.CIR.88.5.2337","article-title":"Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion of dogs","volume":"88","author":"Lefer","year":"1993","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0200","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/01.CIR.78.4.906","article-title":"Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location","volume":"78","author":"Jugdutt","year":"1988","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0205","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/01.CIR.80.3.458","article-title":"Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans","volume":"80","author":"Cox","year":"1989","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0210","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.pharmthera.2014.06.003","article-title":"Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches","volume":"144","author":"Tousoulis","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.phrs.2016.12.017_bib0215","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/01.ATV.0000037101.40667.62","article-title":"Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase","volume":"22","author":"Azumi","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0220","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/01.ATV.0000196651.64776.51","article-title":"Coronary artery superoxide production and nox isoform expression in human coronary artery disease","volume":"26","author":"Guzik","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"34","key":"10.1016\/j.phrs.2016.12.017_bib0225","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1093\/eurheartj\/eht249","article-title":"More answers to the still unresolved question of nitrate tolerance","volume":"34","author":"Munzel","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.phrs.2016.12.017_bib0230","first-page":"4793","article-title":"Role of short-acting nitroglycerin in the management of ischemic heart disease","volume":"9","author":"Boden","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0235","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1089\/ars.2010.3269","article-title":"Chronic administration of the HNO donor Angeli\u2019s salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA\/NO","volume":"14","author":"Irvine","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0240","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/01.HYP.0000259328.04159.90","article-title":"Nitroxyl anion donor: Angeli\u2019s salt, does not develop tolerance in rat isolated aortae","volume":"49","author":"Irvine","year":"2007","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/CS20140759","article-title":"Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance","volume":"129","author":"Andrews","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0250","first-page":"1601","article-title":"Is there a role for antioxidants in the treatment of stable angina?","volume":"19","author":"Schuler","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phrs.2016.12.017_bib0255","doi-asserted-by":"crossref","first-page":"f10","DOI":"10.1136\/bmj.f10","article-title":"Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials","volume":"346","author":"Myung","year":"2013","journal-title":"BMJ"},{"issue":"9374","key":"10.1016\/j.phrs.2016.12.017_bib0260","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0140-6736(03)13637-9","article-title":"Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials","volume":"361","author":"Vivekananthan","year":"2003","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.phrs.2016.12.017_bib0265","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1089\/ars.2015.6393","article-title":"Antioxidants in translational medicine","volume":"23","author":"Schmidt","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"9587","key":"10.1016\/j.phrs.2016.12.017_bib0270","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(07)61299-9","article-title":"Essential hypertension","volume":"370","author":"Messerli","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0275","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1161\/01.HYP.0000138070.47616.9d","article-title":"Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?","volume":"44","author":"Touyz","year":"2004","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0280","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cmet.2008.03.010","article-title":"Hypertension and cerebrovascular dysfunction","volume":"7","author":"Iadecola","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.phrs.2016.12.017_bib0285","doi-asserted-by":"crossref","first-page":"406960","DOI":"10.1155\/2014\/406960","article-title":"Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension","volume":"2014","author":"Dinh","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0290","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/hr.2011.39","article-title":"Oxidative stress and endothelial dysfunction in hypertension","volume":"34","author":"Schulz","year":"2011","journal-title":"Hypertens. Res."},{"issue":"22","key":"10.1016\/j.phrs.2016.12.017_bib0295","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1073\/pnas.88.22.10045","article-title":"Does superoxide underlie the pathogenesis of hypertension?","volume":"88","author":"Nakazono","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0300","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","article-title":"Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells","volume":"74","author":"Griendling","year":"1994","journal-title":"Circ. Res."},{"issue":"6 Pt. 2","key":"10.1016\/j.phrs.2016.12.017_bib0305","first-page":"H2568","article-title":"NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium","volume":"266","author":"Mohazzab","year":"1994","journal-title":"Am. J. Physiol."},{"issue":"8","key":"10.1016\/j.phrs.2016.12.017_bib0310","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1172\/JCI118623","article-title":"Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/NADPH oxidase activation. Contribution to alterations of vasomotor tone","volume":"97","author":"Rajagopalan","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0315","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.CIR.95.3.588","article-title":"Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension","volume":"95","author":"Laursen","year":"1997","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0320","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.RES.80.1.45","article-title":"p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats","volume":"80","author":"Fukui","year":"1997","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.phrs.2016.12.017_bib0325","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0891-5849(01)00727-4","article-title":"Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo","volume":"31","author":"Wingler","year":"2001","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.phrs.2016.12.017_bib0330","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1006\/bbrc.2001.5312","article-title":"Upregulation of vascular NAD(P)H oxidase subunit gp91phox and impairment of the nitric oxide signal transduction pathway in hypertension","volume":"285","author":"Morawietz","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0335","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.109.149187","article-title":"Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1\/2 is reversed by NADPH oxidase inhibition","volume":"56","author":"Wind","year":"2010","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0340","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1097\/HJH.0000000000000259","article-title":"Chronic aldosterone administration causes Nox2-mediated increases in reactive oxygen species production and endothelial dysfunction in the cerebral circulation","volume":"32","author":"Chrissobolis","year":"2014","journal-title":"J. Hypertens."},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0345","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/01.HYP.0000032100.23772.98","article-title":"Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II","volume":"40","author":"Landmesser","year":"2002","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0350","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1161\/hh0901.089987","article-title":"Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice","volume":"88","author":"Wang","year":"2001","journal-title":"Circ. Res."},{"issue":"17","key":"10.1016\/j.phrs.2016.12.017_bib0355","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/CIRCULATIONAHA.105.573709","article-title":"Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice","volume":"112","author":"Matsuno","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0360","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.febslet.2005.12.049","article-title":"Decreased blood pressure in NOX1-deficient mice","volume":"580","author":"Gavazzi","year":"2006","journal-title":"FEBS Lett."},{"issue":"17","key":"10.1016\/j.phrs.2016.12.017_bib0365","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/CIRCULATIONAHA.105.538934","article-title":"Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice","volume":"112","author":"Dikalova","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0370","doi-asserted-by":"crossref","first-page":"H673","DOI":"10.1152\/ajpheart.00242.2010","article-title":"Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling","volume":"299","author":"Dikalova","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0375","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00395-011-0179-7","article-title":"Role of endothelial Nox2 NADPH oxidase in angiotensin II-induced hypertension and vasomotor dysfunction","volume":"106","author":"Murdoch","year":"2011","journal-title":"Basic Res. Cardiol."},{"issue":"7","key":"10.1016\/j.phrs.2016.12.017_bib0380","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.RES.0000263381.83835.7b","article-title":"Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice","volume":"100","author":"Bendall","year":"2007","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0385","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1161\/01.STR.0000112974.37028.58","article-title":"Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo","volume":"35","author":"Paravicini","year":"2004","journal-title":"Stroke"},{"issue":"22","key":"10.1016\/j.phrs.2016.12.017_bib0390","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/eurheartj\/ehv564","article-title":"NADPH oxidase 4 protects against development of endothelial dysfunction and atherosclerosis in LDL receptor deficient mice","volume":"37","author":"Langbein","year":"2016","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0395","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/ATVBAHA.110.219238","article-title":"Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo","volume":"31","author":"Ray","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0400","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1161\/CIRCRESAHA.112.267054","article-title":"Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase","volume":"110","author":"Schroder","year":"2012","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0405","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/01.RES.86.3.347","article-title":"Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide","volume":"86","author":"Drummond","year":"2000","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.phrs.2016.12.017_bib0410","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/hq1001.097028","article-title":"Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)\/calmodulin-dependent protein kinase II\/janus kinase 2-dependent pathway","volume":"21","author":"Cai","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2016.12.017_bib0415","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1074\/jbc.M109107200","article-title":"Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway","volume":"277","author":"Thomas","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.12.017_bib0420","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.freeradbiomed.2015.08.014","article-title":"NOX4-dependent hydrogen peroxide promotes shear stress-induced SHP2 sulfenylation and eNOS activation","volume":"89","author":"Sanchez-Gomez","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0425","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1124\/jpet.111.183400","article-title":"The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways","volume":"339","author":"Joshi","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0430","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1160\/TH04-09-0582","article-title":"The NO\/cGMP pathway inhibits Rap 1 activation in human platelets via cGMP-dependent protein kinase I","volume":"93","author":"Danielewski","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.phrs.2016.12.017_bib0435","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1073\/pnas.0304264101","article-title":"Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment","volume":"101","author":"Ahluwalia","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0440","first-page":"E85","article-title":"Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors","volume":"86","author":"Guzik","year":"2000","journal-title":"Circ. Res."},{"issue":"22","key":"10.1016\/j.phrs.2016.12.017_bib0445","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2008.07.063","article-title":"Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease","volume":"52","author":"Guzik","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0450","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.RES.0000024106.81401.95","article-title":"Increased NADPH oxidase activity: gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits","volume":"91","author":"Paravicini","year":"2002","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0455","doi-asserted-by":"crossref","first-page":"H24","DOI":"10.1152\/ajpheart.00799.2009","article-title":"Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-\/- mice","volume":"298","author":"Judkins","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.phrs.2016.12.017_bib0460","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1161\/ATVBAHA.112.256107","article-title":"Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis","volume":"32","author":"Stanic","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"10.1016\/j.phrs.2016.12.017_bib0465","doi-asserted-by":"crossref","first-page":"e48326","DOI":"10.1371\/journal.pone.0048326","article-title":"NOX2beta: a novel splice variant of NOX2 that regulates NADPH oxidase activity in macrophages","volume":"7","author":"Harrison","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0470","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3109\/10715762.2014.992893","article-title":"NOX1 deficiency in apolipoprotein E-knockout mice is associated with elevated plasma lipids and enhanced atherosclerosis","volume":"49","author":"Sobey","year":"2015","journal-title":"Free Radic. Res."},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0475","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/STROKEAHA.109.575365","article-title":"Augmented superoxide production by Nox2-containing NADPH oxidase causes cerebral artery dysfunction during hypercholesterolemia","volume":"41","author":"Miller","year":"2010","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.phrs.2016.12.017_bib0480","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1172\/JCI200111927","article-title":"p47phox is required for atherosclerotic lesion progression in ApoE(-\/-) mice","volume":"108","author":"Barry-Lane","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0485","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cardiores.2007.06.005","article-title":"Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits","volume":"75","author":"Chan","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0490","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2011.02.028","article-title":"Role for Nox1 NADPH oxidase in atherosclerosis","volume":"216","author":"Sheehan","year":"2011","journal-title":"Atherosclerosis"},{"issue":"18","key":"10.1016\/j.phrs.2016.12.017_bib0495","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.112.132159","article-title":"NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis","volume":"127","author":"Gray","year":"2013","journal-title":"Circulation"},{"issue":"48","key":"10.1016\/j.phrs.2016.12.017_bib0500","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1093\/eurheartj\/ehv460","article-title":"The NADPH oxidase Nox4 has anti-atherosclerotic functions","volume":"36","author":"Schurmann","year":"2015","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0505","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/ATVBAHA.115.307012","article-title":"Reactive oxygen species can provide atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling","volume":"36","author":"Gray","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.12.017_bib0510","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.freeradbiomed.2016.07.013","article-title":"NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis","volume":"97","author":"Di Marco","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2016.12.017_bib0515","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.freeradbiomed.2014.10.593","article-title":"SFRR-E Young Investigator AwardeeNOXing out stroke: identification of NOX4 and 5as targets in blood-brain-barrier stabilisation and neuroprotection","volume":"75","author":"Kleikers","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.phrs.2016.12.017_bib0520","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/00004647-199609000-00023","article-title":"Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-l-arginine","volume":"16","author":"Huang","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0525","doi-asserted-by":"crossref","first-page":"H1042","DOI":"10.1152\/ajpheart.00800.2006","article-title":"Peroxynitrite diminishes myogenic tone in cerebral arteries: role of nitrotyrosine and F-actin","volume":"292","author":"Maneen","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0530","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/nm.2022","article-title":"Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery","volume":"15","author":"Yemisci","year":"2009","journal-title":"Nat. Med."},{"issue":"27","key":"10.1016\/j.phrs.2016.12.017_bib0535","doi-asserted-by":"crossref","first-page":"7083","DOI":"10.1523\/JNEUROSCI.1645-07.2007","article-title":"Neurovascular protection by ischemic tolerance: role of nitric oxide and reactive oxygen species","volume":"27","author":"Kunz","year":"2007","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.phrs.2016.12.017_bib0540","doi-asserted-by":"crossref","first-page":"e28393","DOI":"10.1371\/journal.pone.0028393","article-title":"Nox2 oxidase activity accounts for the oxidative stress and vasomotor dysfunction in mouse cerebral arteries following ischemic stroke","volume":"6","author":"De Silva","year":"2011","journal-title":"PLoS One"},{"issue":"4 Pt. 2","key":"10.1016\/j.phrs.2016.12.017_bib0545","first-page":"H1234","article-title":"Cytochemical detection of superoxide in cerebral inflammation and ischemia in vivo","volume":"263","author":"Kontos","year":"1992","journal-title":"Am. J. Physiol."},{"issue":"5 Pt. 2","key":"10.1016\/j.phrs.2016.12.017_bib0550","first-page":"H1356","article-title":"Oxygen radicals in cerebral ischemia","volume":"263","author":"Nelson","year":"1992","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0555","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2006.06.082","article-title":"NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke","volume":"1111","author":"Miller","year":"2006","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0560","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1476-5381.2008.00073.x","article-title":"Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice","volume":"156","author":"Jackman","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2016.12.017_bib0565","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1161\/STROKEAHA.107.489765","article-title":"NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke","volume":"38","author":"Kahles","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2016.12.017_bib0570","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2009.06.056","article-title":"Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke","volume":"1286","author":"Jackman","year":"2009","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0575","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nbd.2010.05.023","article-title":"NADPH oxidase Nox1 contributes to ischemic injury in experimental stroke in mice","volume":"40","author":"Kahles","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2016.12.017_bib0580","first-page":"62","article-title":"Edema formation exacerbates neurological and histological outcomes after focal cerebral ischemia in CuZn-superoxide dismutase gene knockout mutant mice","volume":"70","author":"Kondo","year":"1997","journal-title":"Acta Neurochir. Suppl."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0585","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(99)00316-X","article-title":"Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse","volume":"267","author":"Sheng","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0590","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1471-4159.2008.05605.x","article-title":"Absence of glutathione peroxidase-1 exacerbates cerebral ischemia-reperfusion injury by reducing post-ischemic microvascular perfusion","volume":"107","author":"Wong","year":"2008","journal-title":"J. Neurochem."},{"issue":"17","key":"10.1016\/j.phrs.2016.12.017_bib0595","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1161\/CIRCULATIONAHA.105.593046","article-title":"Role of T lymphocytes and interferon-gamma in ischemic stroke","volume":"113","author":"Yilmaz","year":"2006","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.phrs.2016.12.017_bib0600","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/sj.jcbfm.9600482","article-title":"T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation","volume":"27","author":"Hurn","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"7","key":"10.1016\/j.phrs.2016.12.017_bib0605","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/jcbfm.2010.14","article-title":"Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide","volume":"30","author":"Brait","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.phrs.2016.12.017_bib0610","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fncel.2014.00365","article-title":"Brain immune cell composition and functional outcome after cerebral ischemia: comparison of two mouse strains","volume":"8","author":"Kim","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0615","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/jcbfm.2013.217","article-title":"Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia","volume":"34","author":"Chu","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"7","key":"10.1016\/j.phrs.2016.12.017_bib0620","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1161\/STROKEAHA.115.009426","article-title":"Evidence that Ly6C(hi) monocytes are protective in acute ischemic stroke by promoting M2 macrophage polarization","volume":"46","author":"Chu","year":"2015","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0625","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/STROKEAHA.114.007298","article-title":"Effect of a broad-specificity chemokine-binding protein on brain leukocyte infiltration and infarct development","volume":"46","author":"Lee","year":"2015","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0630","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1020706316429","article-title":"Regulation of cardiac remodeling by nitric oxide: focus on cardiac myocyte hypertrophy and apoptosis","volume":"7","author":"Wollert","year":"2002","journal-title":"Heart Fail. Rev."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0635","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1006\/jmcc.2000.1149","article-title":"Endothelial dysfunction limits the antihypertrophic action of bradykinin in rat cardiomyocytes","volume":"32","author":"Rosenkranz","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0640","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1172\/JCI119883","article-title":"Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts","volume":"101","author":"Calderone","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0645","doi-asserted-by":"crossref","first-page":"H1070","DOI":"10.1152\/ajpheart.00940.2003","article-title":"Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency","volume":"286","author":"Ichinose","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0650","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijcard.2010.02.024","article-title":"Lack of association between aortic sclerosis and left ventricular hypertrophy in elderly subjects","volume":"150","author":"Nightingale","year":"2011","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.phrs.2016.12.017_bib0655","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1161\/01.CIR.89.5.2070","article-title":"Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion","volume":"89","author":"Paulus","year":"1994","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0660","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/01.CIR.74.4.815","article-title":"The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy","volume":"74","author":"Carroll","year":"1986","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.phrs.2016.12.017_bib0665","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1111\/bph.12568","article-title":"The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli\u2019s salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms","volume":"171","author":"Chin","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0670","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCRESAHA.109.209452","article-title":"Protein S-nitrosylation and cardioprotection","volume":"106","author":"Sun","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2016.12.017_bib0675","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ejphar.2015.09.018","article-title":"Inhibition of the nitric oxide\/cyclic guanosine monophosphate pathway limited the cardioprotective effect of post-conditioning in hearts with apical myocardial infarction","volume":"765","author":"Correa","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0680","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0008-6363(02)00675-2","article-title":"The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart","volume":"57","author":"Bell","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0685","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0008-6363(02)00649-1","article-title":"Attenuation of myocardial ischemia\/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase","volume":"57","author":"Brunner","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.fjc.0000189601.12276.8b","article-title":"Sodium nitroprusside protects adult rat cardiac myocytes from cellular injury induced by simulated ischemia: role for a non-cGMP-dependent mechanism of nitric oxide protection","volume":"47","author":"Garreffa","year":"2006","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2016.12.017_bib0695","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.freeradbiomed.2012.09.005","article-title":"Essential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)ation versus sGC\/cGMP\/PKG signaling?","volume":"54","author":"Sun","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0700","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/08941930802709470","article-title":"Nitric oxide mechanism of protection in ischemia and reperfusion injury","volume":"22","author":"Phillips","year":"2009","journal-title":"J. Invest. Surg."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0705","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00392-007-0588-7","article-title":"New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance","volume":"97","author":"Daiber","year":"2008","journal-title":"Clin. Res. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0710","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.coph.2012.12.008","article-title":"Nitrate therapy and nitrate tolerance in patients with coronary artery disease","volume":"13","author":"Munzel","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"issue":"34","key":"10.1016\/j.phrs.2016.12.017_bib0715","doi-asserted-by":"crossref","first-page":"12159","DOI":"10.1073\/pnas.0503723102","article-title":"An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0720","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1172\/JCI200419267","article-title":"Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance","volume":"113","author":"Sydow","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"41","key":"10.1016\/j.phrs.2016.12.017_bib0725","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1093\/eurheartj\/ehs100","article-title":"Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression","volume":"34","author":"Oelze","year":"2013","journal-title":"Eur. Heart J."},{"issue":"December 9","key":"10.1016\/j.phrs.2016.12.017_bib0730","article-title":"Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function","author":"Daiber","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0735","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1161\/01.CIR.84.6.2336","article-title":"Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin","volume":"84","author":"Parker","year":"1991","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0740","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/FJC.0b013e3181ed2dae","article-title":"Standard versus low-dose transdermal nitroglycerin: differential effects on the development of tolerance and abnormalities of endothelial function","volume":"56","author":"Uxa","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"16","key":"10.1016\/j.phrs.2016.12.017_bib0745","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.107.712133","article-title":"Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation","volume":"116","author":"Dejam","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0750","doi-asserted-by":"crossref","first-page":"H1405","DOI":"10.1152\/ajpheart.00489.2011","article-title":"Vasorelaxant and antiaggregatory actions of the nitroxyl donor isopropylamine NONOate are maintained in hypercholesterolemia","volume":"301","author":"Bullen","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0755","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pharmthera.2007.06.012","article-title":"Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier?","volume":"116","author":"Chirkov","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"18","key":"10.1016\/j.phrs.2016.12.017_bib0760","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1021\/bi00184a036","article-title":"Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states","volume":"33","author":"Stone","year":"1994","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0765","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2006.08.053","article-title":"The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration","volume":"49","author":"Worthley","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2016.12.017_bib0770","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijcard.2014.10.137","article-title":"Impaired platelet nitric oxide response in patients with new onset atrial fibrillation","volume":"179","author":"Procter","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2016.12.017_bib0775","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.niox.2013.08.006","article-title":"The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsiveness","volume":"35","author":"Dautov","year":"2013","journal-title":"Nitric Oxide"},{"issue":"24","key":"10.1016\/j.phrs.2016.12.017_bib0780","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1053\/euhj.2002.3296","article-title":"Beneficial clinical effects of perhexiline in patients with stable angina pectoris and acute coronary syndromes are associated with potentiation of platelet responsiveness to nitric oxide","volume":"23","author":"Willoughby","year":"2002","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.phrs.2016.12.017_bib0785","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.amjcard.2004.02.052","article-title":"Effect of perindopril on platelet nitric oxide resistance in patients with chronic heart failure secondary to ischemic left ventricular dysfunction","volume":"93","author":"Chirkov","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"8","key":"10.1016\/j.phrs.2016.12.017_bib0790","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/hrt.2005.068270","article-title":"Oxidative stress and redox signalling in cardiac hypertrophy and heart failure","volume":"93","author":"Seddon","year":"2007","journal-title":"Heart"},{"issue":"9326","key":"10.1016\/j.phrs.2016.12.017_bib0795","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)09328-5","article-title":"MRC\/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0800","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"October 1","key":"10.1016\/j.phrs.2016.12.017_bib0805","article-title":"New pharmacological approaches to the prevention of myocardial ischemia-reperfusion injury","author":"Chin","year":"2015","journal-title":"Curr. Drug Targets"},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0810","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/bi962493j","article-title":"Role of alpha-tocopheroxyl radical in the initiation of lipid peroxidation in human low-density lipoprotein exposed to horse radish peroxidase","volume":"36","author":"Witting","year":"1997","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.phrs.2016.12.017_bib0815","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1021\/tx9900472","article-title":"Lipid oxidation in human low-density lipoprotein induced by metmyoglobin\/H2O2: involvement of alpha-tocopheroxyl and phosphatidylcholine alkoxyl radicals","volume":"12","author":"Witting","year":"1999","journal-title":"Chem. Res. Toxicol."},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0820","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1089\/ars.2010.3327","article-title":"Nitroxyl (HNO) as a vasoprotective signaling molecule","volume":"14","author":"Bullen","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"12","key":"10.1016\/j.phrs.2016.12.017_bib0825","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.tips.2008.08.005","article-title":"Nitroxyl (HNO): the Cinderella of the nitric oxide story","volume":"29","author":"Irvine","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0830","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pharmthera.2006.11.002","article-title":"The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO","volume":"113","author":"Paolocci","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"18","key":"10.1016\/j.phrs.2016.12.017_bib0835","doi-asserted-by":"crossref","first-page":"10463","DOI":"10.1073\/pnas.181191198","article-title":"Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling","volume":"98","author":"Paolocci","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0840","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1073\/pnas.0937302100","article-title":"Positive inotropic and lusitropic effects of HNO\/NO- in failing hearts: independence from beta-adrenergic signaling","volume":"100","author":"Paolocci","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.phrs.2016.12.017_bib0845","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.phrs.2012.07.010","article-title":"Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta","volume":"66","author":"Leo","year":"2012","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0850","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0003-9861(02)00031-0","article-title":"Further evidence for distinct reactive intermediates from nitroxyl and peroxynitrite: effects of buffer composition on the chemistry of Angeli\u2019s salt and synthetic peroxynitrite","volume":"401","author":"Miranda","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0855","doi-asserted-by":"crossref","first-page":"H939","DOI":"10.1152\/ajpheart.00630.2012","article-title":"Nitroxyl donors retain their depressor effects in hypertension","volume":"305","author":"Irvine","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0860","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2011.07.002","article-title":"Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses","volume":"65","author":"Wynne","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2016.12.017_bib0865","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jinorgbio.2012.08.027","article-title":"A comparison of the chemistry associated with the biological signaling and actions of nitroxyl (HNO) and nitric oxide (NO)","volume":"118","author":"Fukuto","year":"2013","journal-title":"J. Inorg. Biochem."},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0870","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ceca.2004.07.001","article-title":"Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors","volume":"37","author":"Cheong","year":"2005","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.phrs.2016.12.017_bib0875","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.RES.0000253904.53601.c9","article-title":"Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling","volume":"100","author":"Tocchetti","year":"2007","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0880","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/01.HYP.0000072010.54901.DE","article-title":"NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries","volume":"41","author":"Irvine","year":"2003","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0885","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1476-5381.2009.00150.x","article-title":"A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries","volume":"157","author":"Andrews","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0890","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cardiores.2006.11.018","article-title":"The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature","volume":"73","author":"Favaloro","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0895","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-3565(25)10384-4","article-title":"The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and\/or endothelium-derived relaxing factor","volume":"263","author":"Fukuto","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0900","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1160\/TH05-01-0062","article-title":"Effect of nitroxyl on human platelets function","volume":"94","author":"Bermejo","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"18","key":"10.1016\/j.phrs.2016.12.017_bib0905","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1042\/CS20160097","article-title":"Nitroxyl (HNO) reduces endothelial and monocyte activation and promotes M2 macrophage polarisation","volume":"130","author":"Andrews","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.phrs.2016.12.017_bib0910","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2013.02.025","article-title":"Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity","volume":"60","author":"Miller","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0915","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/HYPERTENSIONAHA.114.04285","article-title":"Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse","volume":"65","author":"Zhu","year":"2015","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.phrs.2016.12.017_bib0920","doi-asserted-by":"crossref","first-page":"H1274","DOI":"10.1152\/ajpheart.00008.2009","article-title":"Redox variants of NO (NO{middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms","volume":"296","author":"Favaloro","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"14","key":"10.1016\/j.phrs.2016.12.017_bib0925","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s40265-016-0631-y","article-title":"Therapeutic potential of nitroxyl (HNO) donors in the management of acute decompensated heart failure","volume":"76","author":"Kemp-Harper","year":"2016","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0930","doi-asserted-by":"crossref","first-page":"e34892","DOI":"10.1371\/journal.pone.0034892","article-title":"Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib0935","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1089\/ars.2010.3859","article-title":"Playing with cardiac redox switches: the HNO way to modulate cardiac function","volume":"14","author":"Tocchetti","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"Pt. 3","key":"10.1016\/j.phrs.2016.12.017_bib0940","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1113\/jphysiol.2007.129254","article-title":"Nitroxyl increases force development in rat cardiac muscle","volume":"580","author":"Dai","year":"2007","journal-title":"J. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0945","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCRESAHA.108.188441","article-title":"Nitroxyl activates SERCA in cardiac myocytes via glutathiolation of cysteine 674","volume":"104","author":"Lancel","year":"2009","journal-title":"Circ. Res."},{"issue":"30","key":"10.1016\/j.phrs.2016.12.017_bib0950","doi-asserted-by":"crossref","first-page":"9687","DOI":"10.1021\/ja062365a","article-title":"Hydrolysis of acyloxy nitroso compounds yields nitroxyl (HNO)","volume":"128","author":"Sha","year":"2006","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib0955","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbrc.2010.10.030","article-title":"The new HNO donor, 1-nitrosocyclohexyl acetate, increases contractile force in normal and beta-adrenergically desensitized ventricular myocytes","volume":"402","author":"El-Armouche","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0960","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1021\/jm101432z","article-title":"Acyloxy nitroso compounds as nitroxyl (HNO) donors: kinetics, reactions with thiols, and vasodilation properties","volume":"54","author":"Shoman","year":"2011","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0965","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCHEARTFAILURE.113.000632","article-title":"Nitroxyl (HNO): a novel approach for the acute treatment of heart failure","volume":"6","author":"Sabbah","year":"2013","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"10.1016\/j.phrs.2016.12.017_bib0970","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCHEARTFAILURE.114.001699","article-title":"Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo","volume":"8","author":"Cao","year":"2015","journal-title":"Circ. Heart Fail."},{"issue":"10","key":"10.1016\/j.phrs.2016.12.017_bib0975","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.0000189301.10217.87","article-title":"NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries","volume":"97","author":"Miller","year":"2005","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.phrs.2016.12.017_bib0980","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/STROKEAHA.108.531707","article-title":"Gender influences cerebral vascular responses to angiotensin II through Nox2-derived reactive oxygen species","volume":"40","author":"De Silva","year":"2009","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.phrs.2016.12.017_bib0985","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.bjp.0707322","article-title":"Influence of rosuvastatin on the NAD(P)H oxidase activity in the retina and electroretinographic response of spontaneously hypertensive rats","volume":"151","author":"Sicard","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib0990","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.HYP.37.6.1450","article-title":"HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species","volume":"37","author":"Wassmann","year":"2001","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.phrs.2016.12.017_bib0995","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.2337\/diabetes.53.5.1352","article-title":"Cerebrovascular dysfunction in Zucker obese rats is mediated by oxidative stress and protein kinase C","volume":"53","author":"Erdos","year":"2004","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.phrs.2016.12.017_bib1000","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.amjhyper.2005.05.022","article-title":"Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension","volume":"18","author":"Bayorh","year":"2005","journal-title":"Am. J. Hypertens."},{"issue":"6","key":"10.1016\/j.phrs.2016.12.017_bib1005","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/sj.jcbfm.9600235","article-title":"Flow-induced cerebral vasodilatation in vivo involves activation of phosphatidylinositol-3 kinase, NADPH-oxidase, and nitric oxide synthase","volume":"26","author":"Paravicini","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"2","key":"10.1016\/j.phrs.2016.12.017_bib1010","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1124\/jpet.105.096610","article-title":"NADPH-induced contractions of mouse aorta do not involve NADPH oxidase: a role for P2X receptors","volume":"317","author":"Judkins","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2016.12.017_bib1015","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/jcbfm.2009.47","article-title":"Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion","volume":"29","author":"Chen","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib1020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000479","article-title":"Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration","volume":"8","author":"Kleinschnitz","year":"2010","journal-title":"PLoS Biol."},{"issue":"9","key":"10.1016\/j.phrs.2016.12.017_bib1025","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.freeradbiomed.2012.02.046","article-title":"Off-target thiol alkylation by the NADPH oxidase inhibitor 3-benzyl-7-(2-benzoxazolyl)thio-1,2,3-triazolo[4,5-d]pyrimidine (VAS2870)","volume":"52","author":"Sun","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"21","key":"10.1016\/j.phrs.2016.12.017_bib1030","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1021\/jm100773e","article-title":"First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis","volume":"53","author":"Laleu","year":"2010","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2016.12.017_bib1035","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1089\/ars.2013.5814","article-title":"Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement","volume":"23","author":"Altenhofer","year":"2015","journal-title":"Antioxid. Redox Signal."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816313391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816313391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T12:59:56Z","timestamp":1749819596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816313391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":207,"alternative-id":["S1043661816313391"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.12.017","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The opposing roles of NO and oxidative stress in cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}